The State of Michigan has received its first shipment of two oral medications intended to treat COVID-19, the Michigan Department of Health & Human Services announced.

The medications, paxlovid and molnupiravir, were recently granted emergency use authorization by the FDA.

The antiviral medications are designed for outpatient treatment in mild to moderate COVID-19 cases. Both must be prescribed to a patient by physicians, physician assistants, and advanced practice registered nurses.

Because the state has a limited supply of these drugs, MDHHS has issued eligibility criteria for receiving them.

Criteria will remain in effect until supply of the drugs can meet the demand.

Click here for more information.